300942 易瑞生物
已收盘 12-17 15:00:00
资讯
新帖
简况
12月3日易瑞生物现1笔折价12.7%的大宗交易 合计成交352万元
证券之星 · 12-03
12月3日易瑞生物现1笔折价12.7%的大宗交易 合计成交352万元
12月1日易瑞生物现1笔折价13.56%的大宗交易 合计成交220万元
证券之星 · 12-01
12月1日易瑞生物现1笔折价13.56%的大宗交易 合计成交220万元
11月28日易瑞生物现1笔折价13.81%的大宗交易 合计成交501.6万元
证券之星 · 11-28
11月28日易瑞生物现1笔折价13.81%的大宗交易 合计成交501.6万元
11月27日易瑞生物现1笔折价13.04%的大宗交易 合计成交202.4万元
证券之星 · 11-27
11月27日易瑞生物现1笔折价13.04%的大宗交易 合计成交202.4万元
易瑞生物（300942）披露关于募集资金专项账户全部注销完成的公告，11月14日股价上涨1.37%
证券之星 · 11-14
易瑞生物（300942）披露关于募集资金专项账户全部注销完成的公告，11月14日股价上涨1.37%
股市必读：11月12日易瑞生物现2笔折价10.46%的大宗交易 合计成交488万元
证券之星 · 11-13
股市必读：11月12日易瑞生物现2笔折价10.46%的大宗交易 合计成交488万元
易瑞生物（300942）2025年三季报简析：营收净利润同比双双增长，有存贷双高现象
证券之星 · 10-29
易瑞生物（300942）2025年三季报简析：营收净利润同比双双增长，有存贷双高现象
图解易瑞生物三季报：第三季度单季净利润同比增长187.43%
证券之星 · 10-27
图解易瑞生物三季报：第三季度单季净利润同比增长187.43%
易瑞生物（300942）披露控股股东及其一致行动人减持股份的预披露公告，10月13日股价下跌3.62%
证券之星 · 10-13
易瑞生物（300942）披露控股股东及其一致行动人减持股份的预披露公告，10月13日股价下跌3.62%
易瑞生物最新公告：控股股东及其一致行动人拟减持不超过3%公司股份
证券之星 · 10-12
易瑞生物最新公告：控股股东及其一致行动人拟减持不超过3%公司股份
9月5日易瑞生物现6笔折价21.32%的大宗交易 合计成交1538.8万元
证券之星 · 09-05
9月5日易瑞生物现6笔折价21.32%的大宗交易 合计成交1538.8万元
9月4日易瑞生物现5笔折价19.33%的大宗交易 合计成交1310.86万元
证券之星 · 09-04
9月4日易瑞生物现5笔折价19.33%的大宗交易 合计成交1310.86万元
易瑞生物：公司与多所高校合作开展校园食品安全检测业务
证券之星 · 09-04
易瑞生物：公司与多所高校合作开展校园食品安全检测业务
易瑞生物（300942）2025年中报简析：营收净利润同比双双增长，公司应收账款体量较大
证券之星 · 08-29
易瑞生物（300942）2025年中报简析：营收净利润同比双双增长，公司应收账款体量较大
易瑞生物(300942)6月30日股东户数1.71万户，较上期减少8.48%
证券之星 · 08-28
易瑞生物(300942)6月30日股东户数1.71万户，较上期减少8.48%
图解易瑞生物中报：第二季度单季净利润同比增长2.41%
证券之星 · 08-28
图解易瑞生物中报：第二季度单季净利润同比增长2.41%
易瑞生物最新公告：全资子公司拟出售美国加利福尼亚州仓库资产
证券之星 · 08-27
易瑞生物最新公告：全资子公司拟出售美国加利福尼亚州仓库资产
易瑞生物收盘下跌1.69%，滚动市盈率246.96倍，总市值51.57亿元
金融界 · 08-26
易瑞生物收盘下跌1.69%，滚动市盈率246.96倍，总市值51.57亿元
易瑞生物股价下跌2.01% 公司公告不提前赎回可转债
金融界 · 08-21
易瑞生物股价下跌2.01% 公司公告不提前赎回可转债
易瑞生物收盘下跌1.11%，滚动市盈率258.32倍，总市值53.94亿元
金融界 · 08-19
易瑞生物收盘下跌1.11%，滚动市盈率258.32倍，总市值53.94亿元
加载更多
公司概况
公司名称：
深圳市易瑞生物技术股份有限公司
所属行业：
医药制造业
上市日期：
2021-02-09
主营业务：
深圳市易瑞生物技术股份有限公司的主营业务是食品安全精准快速检测产品的研发、生产、销售及相关服务。公司的主要产品是食品安全快速检测试剂、快速检测仪器及相关快检服务。
发行价格：
5.31
{"stockData":{"symbol":"300942","market":"SZ","secType":"STK","nameCN":"易瑞生物","latestPrice":9.37,"timestamp":1765955034000,"preClose":9.36,"halted":0,"volume":2812100,"delay":0,"changeRate":0.0011,"floatShares":405000000,"shares":405000000,"eps":0.0772,"marketStatus":"已收盘","change":0.01,"latestTime":"12-17 15:00:00","open":9.32,"high":9.42,"low":9.21,"amount":26181300,"amplitude":0.0224,"askPrice":9.38,"askSize":93,"bidPrice":9.37,"bidSize":20,"shortable":0,"etf":0,"ttmEps":0.0772,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766021400000},"marketStatusCode":5,"adr":0,"adjPreClose":9.36,"symbolType":"stock","openAndCloseTimeList":[[1765935000000,1765942200000],[1765947600000,1765954800000]],"highLimit":10.3,"lowLimit":8.42,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":405068764,"isCdr":false,"pbRate":4.48,"roa":"--","peRate":121.373057,"roe":"2.05%","epsLYR":0.04,"committee":-0.375097,"marketValue":3795000000,"turnoverRate":0.0069,"status":0,"floatMarketCap":3795000000},"requestUrl":"/m/hq/s/300942","defaultTab":"news","newsList":[{"id":"2588011351","title":"12月3日易瑞生物现1笔折价12.7%的大宗交易 合计成交352万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588011351","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588011351?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:57","pubTimestamp":1764752275,"startTime":"0","endTime":"0","summary":"证券之星消息，12月3日易瑞生物发生大宗交易，交易数据如下：大宗交易成交价格8.8元，相对当日收盘价折价12.7%，成交40万股，成交金额352万元，买方营业部为机构专用，卖方营业部为东兴证券股份有限公司上海陆家嘴证券营业部。近三个月该股共发生20笔大宗交易，合计成交6.07万手，折价成交20笔。该股近期无解禁股上市。截至2025年12月3日收盘，易瑞生物报收于10.08元，下跌1.08%，换手率0.88%，成交量3.55万手，成交额3585.07万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300025365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300942","BK0239"],"gpt_icon":0},{"id":"2588723078","title":"12月1日易瑞生物现1笔折价13.56%的大宗交易 合计成交220万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588723078","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588723078?lang=zh_cn&edition=full","pubTime":"2025-12-01 17:43","pubTimestamp":1764582204,"startTime":"0","endTime":"0","summary":"证券之星消息，12月1日易瑞生物发生大宗交易，交易数据如下：大宗交易成交价格8.8元，相对当日收盘价折价13.56%，成交25万股，成交金额220万元，买方营业部为甬兴证券有限公司宁波分公司，卖方营业部为东兴证券股份有限公司上海陆家嘴证券营业部。近三个月该股共发生18笔大宗交易，合计成交5.12万手，折价成交18笔。截至2025年12月1日收盘，易瑞生物报收于10.18元，下跌0.29%，换手率1.1%，成交量4.45万手，成交额4546.46万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100022461.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300942"],"gpt_icon":0},{"id":"2586884527","title":"11月28日易瑞生物现1笔折价13.81%的大宗交易 合计成交501.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586884527","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586884527?lang=zh_cn&edition=full","pubTime":"2025-11-28 17:42","pubTimestamp":1764322934,"startTime":"0","endTime":"0","summary":"证券之星消息，11月28日易瑞生物发生大宗交易，交易数据如下：大宗交易成交价格8.8元，相对当日收盘价折价13.81%，成交57万股，成交金额501.6万元，买方营业部为机构专用，卖方营业部为东兴证券股份有限公司上海陆家嘴证券营业部。近三个月该股共发生19笔大宗交易，合计成交6.87万手，折价成交19笔。截至2025年11月28日收盘，易瑞生物报收于10.21元，上涨0.89%，换手率0.75%，成交量3.04万手，成交额3086.73万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800025835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300942"],"gpt_icon":0},{"id":"2586246926","title":"11月27日易瑞生物现1笔折价13.04%的大宗交易 合计成交202.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586246926","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586246926?lang=zh_cn&edition=full","pubTime":"2025-11-27 17:41","pubTimestamp":1764236507,"startTime":"0","endTime":"0","summary":"证券之星消息，11月27日易瑞生物发生大宗交易，交易数据如下：大宗交易成交价格8.8元，相对当日收盘价折价13.04%，成交23万股，成交金额202.4万元，买方营业部为国投证券股份有限公司汕头长平路证券营业部，卖方营业部为东兴证券股份有限公司上海陆家嘴证券营业部。近三个月该股共发生18笔大宗交易，合计成交6.3万手，折价成交18笔。截至2025年11月27日收盘，易瑞生物报收于10.12元，下跌0.2%，换手率0.76%，成交量3.06万手，成交额3100.97万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700025866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300942"],"gpt_icon":0},{"id":"2583050276","title":"易瑞生物（300942）披露关于募集资金专项账户全部注销完成的公告，11月14日股价上涨1.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583050276","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583050276?lang=zh_cn&edition=full","pubTime":"2025-11-14 22:47","pubTimestamp":1763131633,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，易瑞生物报收于11.11元，较前一交易日上涨1.37%，最新总市值为45亿元。该股当日开盘10.96元，最高11.19元，最低10.9元，成交额达9249.65万元，换手率为2.05%。同日，公司发布《关于募集资金专项账户全部注销完成的公告》。公告称，深圳市易瑞生物技术股份有限公司已完成首次公开发行股票及2023年向不特定对象发行可转换公司债券的全部募集资金专项账户注销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400042122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300942","BK0239"],"gpt_icon":0},{"id":"2583110307","title":"股市必读：11月12日易瑞生物现2笔折价10.46%的大宗交易 合计成交488万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583110307","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583110307?lang=zh_cn&edition=full","pubTime":"2025-11-13 04:29","pubTimestamp":1762979347,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，易瑞生物报收于10.9元，上涨1.68%，换手率2.01%，成交量8.15万手，成交额8866.02万元。当日关注点来自交易信息汇总：11月12日主力资金净流出429.39万元，游资资金净流入514.15万元。大宗交易11月12日易瑞生物现2笔折价10.46%的大宗交易，合计成交488万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300004950.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300942","BK0239"],"gpt_icon":0},{"id":"2579916923","title":"易瑞生物（300942）2025年三季报简析：营收净利润同比双双增长，有存贷双高现象","url":"https://stock-news.laohu8.com/highlight/detail?id=2579916923","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579916923?lang=zh_cn&edition=full","pubTime":"2025-10-29 06:43","pubTimestamp":1761691385,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期易瑞生物发布2025年三季报。截至本报告期末，公司营业总收入1.86亿元，同比上升17.45%，归母净利润1802.3万元，同比上升362.49%。本报告期易瑞生物有存贷双高现象，有息资产负债率达30%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900010834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300942"],"gpt_icon":0},{"id":"2578533612","title":"图解易瑞生物三季报：第三季度单季净利润同比增长187.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578533612","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578533612?lang=zh_cn&edition=full","pubTime":"2025-10-27 18:20","pubTimestamp":1761560428,"startTime":"0","endTime":"0","summary":"证券之星消息，易瑞生物2025年三季报显示，公司主营收入1.86亿元，同比上升17.45%；归母净利润1802.3万元，同比上升362.49%；扣非净利润372.85万元，同比上升137.78%；其中2025年第三季度，公司单季度主营收入7634.62万元，同比上升40.34%；单季度归母净利润1568.35万元，同比上升187.43%；单季度扣非净利润578.6万元，同比上升225.48%；负债率38.55%，投资收益-324.35万元，财务费用848.12万元，毛利率64.3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700028254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300942"],"gpt_icon":0},{"id":"2575471822","title":"易瑞生物（300942）披露控股股东及其一致行动人减持股份的预披露公告，10月13日股价下跌3.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575471822","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575471822?lang=zh_cn&edition=full","pubTime":"2025-10-13 17:19","pubTimestamp":1760347187,"startTime":"0","endTime":"0","summary":"截至2025年10月13日收盘，易瑞生物报收于10.12元，较前一交易日下跌3.62%，最新总市值为40.99亿元。同日，公司发布关于控股股东及其一致行动人减持股份的预披露公告。公告显示，深圳市易瑞生物技术股份有限公司控股股东易瑞（海南）创业投资有限公司及其一致行动人深圳易达瑞管理咨询合伙企业、深圳易凯瑞管理咨询合伙企业计划自2025年11月3日至2026年2月2日期间，通过集中竞价或大宗交易方式减持股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300019937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300942","BK0239"],"gpt_icon":0},{"id":"2574995434","title":"易瑞生物最新公告：控股股东及其一致行动人拟减持不超过3%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2574995434","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574995434?lang=zh_cn&edition=full","pubTime":"2025-10-12 16:11","pubTimestamp":1760256668,"startTime":"0","endTime":"0","summary":"易瑞生物(300942.SZ)公告称，公司控股股东易瑞创投及其一致行动人易达瑞、易凯瑞计划自公告披露之日起15个交易日后的3个月内，以集中竞价或大宗交易方式减持公司股份，合计不超过公司总股本的3%。其中，易瑞创投拟减持不超过11,521,758股（占公司总股本2.84%），易达瑞拟减持不超过288,500股（占公司总股本0.07%），易凯瑞拟减持不超过341,800股（占公司总股本0.08%）。减持价格将根据市场价格确定，且不低于公司首次公开发行股票的发行价格。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200004325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300942","BK0239"],"gpt_icon":0},{"id":"2565293556","title":"9月5日易瑞生物现6笔折价21.32%的大宗交易 合计成交1538.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565293556","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565293556?lang=zh_cn&edition=full","pubTime":"2025-09-05 17:26","pubTimestamp":1757064385,"startTime":"0","endTime":"0","summary":"证券之星消息，9月5日易瑞生物发生大宗交易，交易数据如下：近三个月该股共发生23笔大宗交易，合计成交7.43万手，折价成交23笔。该股近期无解禁股上市。截至2025年9月5日收盘，易瑞生物(300942)报收于13.04元，上涨1.64%，换手率2.14%，成交量8.66万手，成交额1.1亿元。该股近半年内有股东持股变动，合计净减持1421.01万股，股东增减持明细如下表：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090500028850.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300942","BK0239"],"gpt_icon":0},{"id":"2564320379","title":"9月4日易瑞生物现5笔折价19.33%的大宗交易 合计成交1310.86万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2564320379","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564320379?lang=zh_cn&edition=full","pubTime":"2025-09-04 17:23","pubTimestamp":1756977827,"startTime":"0","endTime":"0","summary":"证券之星消息，9月4日易瑞生物发生大宗交易，交易数据如下：近三个月该股共发生17笔大宗交易，合计成交5.93万手，折价成交17笔。该股近期无解禁股上市。截至2025年9月4日收盘，易瑞生物(300942)报收于12.83元，下跌0.85%，换手率2.54%，成交量10.28万手，成交额1.34亿元。该股近半年内有股东持股变动，合计净减持1421.01万股，股东增减持明细如下表：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090400027141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300942","BK0239"],"gpt_icon":0},{"id":"2564326178","title":"易瑞生物：公司与多所高校合作开展校园食品安全检测业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2564326178","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564326178?lang=zh_cn&edition=full","pubTime":"2025-09-04 15:03","pubTimestamp":1756969397,"startTime":"0","endTime":"0","summary":"证券之星消息，易瑞生物09月04日在投资者关系平台上答复投资者关心的问题。公司在校园食品安全已有相关检测业务，公司可为校园提供食品检测试剂、在学校里建立快检实验室，对学校食堂采购的各类食材、餐具的洁净程度等进行严格的质量监控，保障校园食品安全。公司与江西科技师范大学、中国农业大学、清华大学等高校已有合作，南京中医药大学未采购公司检测设备。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090400018338.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300942"],"gpt_icon":0},{"id":"2563675430","title":"易瑞生物（300942）2025年中报简析：营收净利润同比双双增长，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2563675430","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563675430?lang=zh_cn&edition=full","pubTime":"2025-08-29 06:42","pubTimestamp":1756420974,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期易瑞生物发布2025年中报。截至本报告期末，公司营业总收入1.09亿元，同比上升5.44%，归母净利润233.95万元，同比上升250.02%。本报告期易瑞生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达525.39%。本次财报公布的各项数据指标表现尚佳。去年的净利率为7.41%，算上全部成本后，公司产品或服务的附加值一般。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082900007262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300942"],"gpt_icon":0},{"id":"2562808752","title":"易瑞生物(300942)6月30日股东户数1.71万户，较上期减少8.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562808752","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562808752?lang=zh_cn&edition=full","pubTime":"2025-08-28 17:41","pubTimestamp":1756374082,"startTime":"0","endTime":"0","summary":"证券之星消息，近日易瑞生物披露，截至2025年6月30日公司股东户数为1.71万户，较3月31日减少1588.0户，减幅为8.48%。在医疗器械行业个股中，易瑞生物股东户数低于行业平均水平，截至6月30日，医疗器械行业平均股东户数为2.21万户。从股价来看，2025年3月31日至2025年6月30日，易瑞生物区间涨幅为9.22%，在此期间股东户数减少1588.0户，减幅为8.48%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800034056.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300942","BK0239"],"gpt_icon":0},{"id":"2562247977","title":"图解易瑞生物中报：第二季度单季净利润同比增长2.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562247977","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562247977?lang=zh_cn&edition=full","pubTime":"2025-08-28 03:06","pubTimestamp":1756321565,"startTime":"0","endTime":"0","summary":"证券之星消息，易瑞生物2025年中报显示，公司主营收入1.09亿元，同比上升5.44%；归母净利润233.95万元，同比上升250.02%；扣非净利润-205.75万元，同比上升60.88%；其中2025年第二季度，公司单季度主营收入5994.45万元，同比下降10.76%；单季度归母净利润568.55万元，同比上升2.41%；单季度扣非净利润304.95万元，同比下降3.48%；负债率39.06%，投资收益-232.31万元，财务费用247.99万元，毛利率64.47%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800002319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300942"],"gpt_icon":0},{"id":"2562747292","title":"易瑞生物最新公告：全资子公司拟出售美国加利福尼亚州仓库资产","url":"https://stock-news.laohu8.com/highlight/detail?id=2562747292","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562747292?lang=zh_cn&edition=full","pubTime":"2025-08-27 22:20","pubTimestamp":1756304443,"startTime":"0","endTime":"0","summary":"易瑞生物(300942.SZ)公告称，公司全资子公司Bioeasy USA Inc.拟出售其位于美国加利福尼亚州的仓库，交易价格为420万美金。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082700051196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300942"],"gpt_icon":0},{"id":"2562847517","title":"易瑞生物收盘下跌1.69%，滚动市盈率246.96倍，总市值51.57亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562847517","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562847517?lang=zh_cn&edition=full","pubTime":"2025-08-26 17:56","pubTimestamp":1756202211,"startTime":"0","endTime":"0","summary":"8月26日，易瑞生物今日收盘12.83元，下跌1.69%，滚动市盈率PE达到246.96倍，总市值51.57亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均65.88倍，行业中值39.66倍，易瑞生物排名第138位。股东方面，截至2025年3月31日，易瑞生物股东户数18731户，较上次增加289户，户均持股市值35.28万元，户均持股数量2.76万股。深圳市易瑞生物技术股份有限公司的主营业务是食品安全快速检测业务。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/26175652704719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","300942"],"gpt_icon":0},{"id":"2561548879","title":"易瑞生物股价下跌2.01% 公司公告不提前赎回可转债","url":"https://stock-news.laohu8.com/highlight/detail?id=2561548879","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561548879?lang=zh_cn&edition=full","pubTime":"2025-08-21 00:26","pubTimestamp":1755707163,"startTime":"0","endTime":"0","summary":"易瑞生物股价报13.15元，较前一交易日下跌2.01%，盘中最高触及13.46元，最低下探至12.96元，成交额1.14亿元。易瑞生物主营业务涵盖食品快速检测、动物疫病检测及体外诊断业务，其中食品快速检测业务占比超90%。公司所属概念板块包括化学制药、痘病毒防治、专精特新等。8月20日，易瑞生物公告称，董事会决定不提前赎回“易瑞转债”，且未来三个月内若再次触发赎回条款，公司仍不行使赎回权利。当日主力资金净流入446.70万元，近五日主力资金累计净流出1049.52万元。风险提示：股市有风险，投资需谨慎。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/21002652576546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300942","BK0239"],"gpt_icon":0},{"id":"2560516747","title":"易瑞生物收盘下跌1.11%，滚动市盈率258.32倍，总市值53.94亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560516747","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560516747?lang=zh_cn&edition=full","pubTime":"2025-08-19 17:56","pubTimestamp":1755597381,"startTime":"0","endTime":"0","summary":"8月19日，易瑞生物今日收盘13.42元，下跌1.11%，滚动市盈率PE达到258.32倍，总市值53.94亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均65.79倍，行业中值37.53倍，易瑞生物排名第138位。股东方面，截至2025年3月31日，易瑞生物股东户数18731户，较上次增加289户，户均持股市值35.28万元，户均持股数量2.76万股。深圳市易瑞生物技术股份有限公司的主营业务是食品安全快速检测业务。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/19175652538235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","300942"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765956008325,"stockEarnings":[{"period":"1week","weight":-0.04},{"period":"1month","weight":-0.1575},{"period":"3month","weight":-0.1598},{"period":"6month","weight":0.0624},{"period":"1year","weight":-0.0343},{"period":"ytd","weight":0.0942}],"compareEarnings":[{"period":"1week","weight":-0.0217},{"period":"1month","weight":-0.0415},{"period":"3month","weight":-0.0133},{"period":"6month","weight":0.1376},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.1411}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳市易瑞生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"16436人(较上一季度减少4.12%)","perCapita":"24645股","listingDate":"2021-02-09","address":"广东省深圳市宝安区航城街道三围社区运昌路289号易瑞生物产业园2栋A101","registeredCapital":"40506万元","survey":" 深圳市易瑞生物技术股份有限公司的主营业务是食品安全精准快速检测产品的研发、生产、销售及相关服务。公司的主要产品是食品安全快速检测试剂、快速检测仪器及相关快检服务。","listedPrice":5.31},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"易瑞生物(300942)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供易瑞生物(300942)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"易瑞生物,300942,易瑞生物股票,易瑞生物股票老虎,易瑞生物股票老虎国际,易瑞生物行情,易瑞生物股票行情,易瑞生物股价,易瑞生物股市,易瑞生物股票价格,易瑞生物股票交易,易瑞生物股票购买,易瑞生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"易瑞生物(300942)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供易瑞生物(300942)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}